$Muc4\sialomucin Complex, A Specific Intramembrane Modulator of ERBB2/HER2/NEU, Potentiates Primary Tumor Growth and Suppresses Apoptosis in A Xenotransplanted Melanoma$

Muc4\sialomucin Complex, A Specific Intramembrane Modulator of ERBB2/HER2/NEU, Potentiates Primary Tumor Growth and Suppresses Apoptosis in A Xenotransplanted Melanoma

Saved in:

Bibliographic Details
Main Authors:	Coralie Carothers Carraway, Masanobu Komatsu, Scott Jepson, Maria Arango, Kermit Carraway
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/tsw.2001.23.248
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
by: Axel Walch, et al.
Published: (2000-01-01)

An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients
by: Athraa Falah Alshimerry
Published: (2025-01-01)

ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)

PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01)

Activation of the Staphylococcus aureus intramembrane sensing histidine kinase SaeS via intramembrane interaction with the bacterially encoded small protein ScrA
by: Marcus A. Wittekind, et al.
Published: (2025-07-01)

MUC1, MUC2, MUC4, MUC5AC, Cdx2: immunohistochemical characteristics in polyps and adenocarcinoma of distal colon
by: M. A. Shyshkin
Published: (2019-05-01)

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab
by: Rodrigo Sánchez-Bayona, et al.
Published: (2025-04-01)

Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
by: O. M. Levyk
Published: (2014-04-01)

Immunohistochemical study of MUC5AC, MUC1, MUC2, Cdx-2 in hyperplastic polyps and intestinal-type gastric adenocarcinoma
by: V. A. Tumanskiy, et al.
Published: (2017-10-01)

ERBB3-related gene PBX1 is associated with prognosis in patients with HER2-positive breast cancer
by: Shufen Mo, et al.
Published: (2025-01-01)

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01)

Myxosortase: an intramembrane protease that sorts MYXO-CTERM proteins to the cell surface
by: Tingting Guo, et al.
Published: (2025-04-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2024-03-01)

Immunohistochemical Study of Ki-67 and HER2/neu and its Correlation with Clinicopathological Features in Surface Epithelial Tumors of the Ovary
by: Sameeksha Alva, et al.
Published: (2025-01-01)

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors
by: Kristian Egebjerg, et al.
Published: (2025-08-01)

Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer
by: Jaekwang Jeong, et al.
Published: (2025-05-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice
by: Maria Laura De Angelis, et al.
Published: (2024-11-01)

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
by: Taha Heba F., et al.
Published: (2021-05-01)

Immunohistochemical Expression of ROS1 in invasive ductal carcinoma of breast in association with hormonal receptor status and Her2Neu expression
by: Muhammad Umair, et al.
Published: (2024-10-01)

Commentary: Oral fluid testing can be used to monitor xenotransplant donor herds for porcine cytomegalovirus/roseolovirus status
by: Joachim Denner
Published: (2025-05-01)

Differences in the distribution of HER2-positive breast tumors according to ethnicity and genetic variants in ERBB2: a special focus on Asian and Latina women
by: Laura Rey-Vargas, et al.
Published: (2025-07-01)

Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale
by: R. M. Paltuev, et al.
Published: (2023-10-01)

Toxoplasma gondii destroys Her2/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach
by: Esra Atalay Şahar, et al.
Published: (2020-10-01)

Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection
by: Kwang Kuk Park, et al.
Published: (2015-01-01)

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort
by: Adam Kowalewski, et al.
Published: (2025-07-01)

MUC2 and MUC5AC expression in colon cancer: A preliminary report from South India
by: R Jayanth, et al.
Published: (2019-01-01)

The аntitumor effect of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) on the growth of spontaneous mammary tumors in HER-2/neu transgenic mice
by: V. A. Alexandrov, et al.
Published: (2023-06-01)

Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer
by: V. Sekhri, et al.
Published: (2024-02-01)

A study of HER-2/neu expression and silver binding nucleolar organizer regions (Ag NORs) in perilesional normal salivary gland tissue
by: Essam Taher M.A. Gaballah
Published: (2010-04-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
by: Catrin Heim, et al.
Published: (2024-06-01)

The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.
by: Jennifer L Miller-Gallacher, et al.
Published: (2014-01-01)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
by: Jesús K. Yamamoto-Furusho, et al.
Published: (2015-01-01)

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu
by: Olga D. Bragina, et al.
Published: (2017-10-01)

Assessing functional suitability of a lyophilized formulation containing designed ankyrin repeat proteins for radionuclide imaging of HER2/neu overexpression in malignant tumors
by: R. N. Varvashenya, et al.
Published: (2024-10-01)

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
by: Philippe Slos, et al.
Published: (2017-11-01)

MUC2 expression modulates immune infiltration in colorectal cancer
by: Christophe M. Raynaud, et al.
Published: (2025-01-01)

Hubungan Overekspresi HER-2/neu dengan Status Reseptor Hormonal dan Grading Histopatologi pada Penderita Karsinoma Payudara di RS Onkologi Surabaya
by: JACOBUS OCTOVIANUS, et al.
Published: (2012-08-01)

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
by: V. V. Tokmakov, et al.
Published: (2020-12-01)